JPM 2022: Eli Lilly gears up for Alzheimer’s-diabetes juggling act as 2 key FDA decisions loom
Summary : On the brink of two major approvals this year, Eli Lilly is laser-focused on diabetes and dementia. One market is…
Summary : On the brink of two major approvals this year, Eli Lilly is laser-focused on diabetes and dementia. One market is…